Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.
| Revenue (Most Recent Fiscal Year) | $4.03B |
| Net Income (Most Recent Fiscal Year) | $456.00M |
| PE Ratio (Current Year Earnings Estimate) | 18.72 |
| PE Ratio (Trailing 12 Months) | 19.46 |
| PEG Ratio (Long Term Growth Estimate) | 2.54 |
| Price to Sales Ratio (Trailing 12 Months) | 4.44 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.79 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 14.07 |
| Pre-Tax Margin (Trailing 12 Months) | 15.83% |
| Net Margin (Trailing 12 Months) | 12.98% |
| Return on Equity (Trailing 12 Months) | 18.91% |
| Return on Assets (Trailing 12 Months) | 10.47% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.89 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.18 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.55 |
| Inventory Turnover (Trailing 12 Months) | 2.98 |
| Book Value per Share (Most Recent Fiscal Quarter) | $20.48 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.98 |
| Earnings per Share (Most Recent Fiscal Year) | $3.96 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.11 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 234.73M |
| Free Float | 230.62M |
| Market Capitalization | $17.63B |
| Average Volume (Last 20 Days) | 1.52M |
| Beta (Past 60 Months) | 1.00 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.75% |
| Percentage Held By Institutions (Latest 13F Reports) | 94.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |